Salivary psoriasin (S100A7) correlates with diffusion capacity of carbon monoxide in a large cohort of systemic sclerosis patients
Authors:
- Laura GiustiLGLaura Giusti
- Francesca SernissiFSFrancesca Sernissi
- Elena DonadioEDElena Donadio
- Federica CiregiaFCFederica Ciregia
- Camillo GiacomelliCGCamillo Giacomelli
- Gino GiannacciniGGGino Giannaccini
- Maria Rosa MazzoniMMMaria Rosa Mazzoni
- Antonio LucacchiniALAntonio Lucacchini
- Laura BazzichiLBLaura Bazzichi
Open Access
- 8 September 2016
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 14 (1) , 262
Abstract
Systemic sclerosis (SSc) is an autoimmune disease characterized by progressive fibrosis of the skin and the internal organs. In a previous work we suggested a correlation between levels of salivary psoriasin (S100A7) and pulmonary involvement in SSc patients. The goals of this study are to determine the distribution characteristics of psoriasin in whole saliva (WS) of SSc and healthy donor populations and define its predictive value on diffusion capacity of carbon monoxide (DLCO), along with others clinical parameters. Salivary level of psoriasin was determined by ELISA kit in 134 SSc patients, 63 Raynaud syndrome patients, 40 patients affected by other connective diseases (non-case) and 74 healthy control subjects. A significant increase of salivary psoriasin was observed in SSc patients when compared with other healthy and pathological controls. Moreover, we confirmed the efficacy of salivary psoriasin to correlate with DLCO in a large cohort of SSc patients. Overall our results suggest a rapid, non invasive and low costing method which can help clinicians in the evaluation of SSc pulmonary involvement.Keywords
This publication has 19 references indexed in Scilit:
- Serum Amyloid A Is a Marker for Pulmonary Involvement in Systemic SclerosisPLOS ONE, 2015
- Interleukin‐17 and interleukin‐23: importance in the pathogenesis of lung impairment in patients with systemic sclerosisInternational Journal of Rheumatic Diseases, 2014
- A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: a focus on potential salivary biomarkersJournal of Translational Medicine, 2013
- One decade of salivary proteomics: Current approaches and outstanding challengesClinical Biochemistry, 2013
- Vitamin D Analog Calcipotriol Suppresses the Th17 Cytokine–Induced Proinflammatory S100 “Alarmins” Psoriasin (S100A7) and Koebnerisin (S100A15) in PsoriasisJournal of Investigative Dermatology, 2012
- Correspondence between salivary proteomic pattern and clinical course in primary Sjögren syndrome and non-Hodgkin's lymphoma: a case reportJournal of Translational Medicine, 2011
- Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and functionAmino Acids, 2010
- Detection of potential markers of primary fibromyalgia syndrome in human salivaProteomics – Clinical Applications, 2009
- Proteome analysis of whole saliva: A new tool for rheumatic diseases – the example of Sjögren's syndromeProteomics, 2007
- Molecular Cloning, Occurrence, and Expression of a Novel Partially Secreted Protein “Psoriasin” That Is Highly Up-Regulated in Psoriatic SkinJournal of Investigative Dermatology, 1991